PubRank

F Mor

Author PubWeight™ 40.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 1999 3.13
2 Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci 2000 1.62
3 T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A 2000 1.61
4 Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells. Science 1989 1.56
5 Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat Med 1996 1.47
6 The significance of paraproteinemia in hairy cell leukemia: case report and review of the literature. Haematologica 1990 1.38
7 Imipramine for the treatment of fibrositis: a therapeutic trial. Ann Rheum Dis 1985 1.11
8 Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 2000 1.10
9 Modulation of proteinase-K resistant prion protein by prion peptide immunization. Eur J Immunol 2001 1.04
10 Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7. Int Immunol 1997 1.01
11 Bacteremia in febrile patients. A clinical model for diagnosis. Arch Intern Med 1991 1.00
12 The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci U S A 1999 0.97
13 Pseudomonas stutzeri causing late prosthetic valve endocarditis. J R Soc Med 1987 0.95
14 Autoimmune T cells retard the loss of function in injured rat optic nerves. J Neuroimmunol 2000 0.92
15 Significance of elevated levels of serum creatine phosphokinase in febrile diseases: a prospective study. Rev Infect Dis 1991 0.90
16 Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J Neuroimmunol 1998 0.90
17 Non-coding plasmid DNA induces IFN-gamma in vivo and suppresses autoimmune encephalomyelitis. Int Immunol 1999 0.88
18 Stress and autoimmunity: the neuropeptides corticotropin-releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J Immunol 1997 0.88
19 Expression of major histocompatibility complex class II molecules in rat T cells. Eur J Immunol 1994 0.86
20 The peptide binding specificity of the MHC class II I-A molecule of the Lewis rat, RT1.BI. Int Immunol 1996 0.86
21 Self prion protein peptides are immunogenic in Lewis rats. J Autoimmun 2001 0.85
22 Myopathy in Addison's disease. Ann Rheum Dis 1987 0.83
23 The peptide-binding strategy of the MHC class II I-A molecules. Immunol Today 1998 0.83
24 Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins. J Autoimmun 2000 0.82
25 T cell immunity to myelin basic protein induces anterior uveitis in Lewis rats. J Neuroimmunol 1994 0.82
26 Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity. J Autoimmun 1995 0.81
27 Peptide binding motifs of the MHC class I molecules (RT1.Al) of the Lewis rat. Immunogenetics 1997 0.81
28 Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome. Ann Rheum Dis 1990 0.79
29 Alpha tropomyosin as a self-antigen in patients with Behçet's disease. Clin Exp Immunol 2005 0.78
30 Effects of vitamin C on pathology and caspase-3 activity of kidneys with subacute endosulfan toxicity. Biotech Histochem 2014 0.78
31 Nasal respiratory support in premature infants: short-term physiological effects and comfort assessment. Acta Paediatr 2008 0.78
32 Non-cardiac use of nitroglycerin patches. Eur Heart J 1988 0.77
33 Diversity of the B cell repertoire to myelin basic protein in rat strains susceptible and resistant to EAE. J Autoimmun 1999 0.77
34 T cells in the spinal cord in experimental autoimmune encephalomyelitis are matrix adherent and secrete tumor necrosis factor alpha. J Neuroimmunol 1992 0.76
35 On the regulation of EAE. Int Rev Immunol 1993 0.76
36 Hood versus mask nebulization in infants with evolving bronchopulmonary dysplasia in the neonatal intensive care unit. J Perinatol 2006 0.76
37 Addison's disease due to metastases to the adrenal glands. Postgrad Med J 1985 0.75
38 Helper CD4+ T cells and HIV-1. Science 1998 0.75
39 Polymyositis mediated by lymphocytes expressing the gamma/delta receptor. N Engl J Med 1991 0.75
40 Cyclosporine. N Engl J Med 1990 0.75
41 Preparation of lymphocytes for autolymphocyte therapy in metastatic renal carcinoma. Lancet 1990 0.75
42 Relationship between systolic time interval measurements and the extent of regional ventricular asynergy in coronary artery disease. Isr J Med Sci 1981 0.75
43 Diagnosis of polymyalgia rheumatica and giant cell arteritis: a note of caution. Isr J Med Sci 1987 0.75
44 Tropomyosin-induced arthritis in rats. Clin Exp Rheumatol 2007 0.75
45 [Revised criteria for rheumatoid arthritis]. Harefuah 1989 0.75
46 Experimental autoimmune keratitis induced in rats by anti-cornea T-cell lines. Invest Ophthalmol Vis Sci 1999 0.75
47 Non-Hodgkin's lymphoma in the elderly: data at presentation. Am J Med 1988 0.75
48 Treatable causes of dementia. Am J Med 1988 0.75
49 [Multiple pulmonary emboli in a patient with lupus anticoagulant]. Harefuah 1985 0.75
50 Functional activation of encephalitogenic T cells in the absence of antigen-presenting cells. Int Immunol 1995 0.75
51 [Leukocytoclastic vasculitis]. Harefuah 1987 0.75